Dr. Gearóid Tuohy

Neurogene Inc. (NYC, USA) has announced to become the first investigative treatment of both neurodegenerative and ocular disease manifestations of Batten Disease.

Neurogene Inc. based in Manhattan, New York City, has announced that the U.S. Food and Drug Administration (FDA) has cleared the company’s Investigational New Drug… Read More »Neurogene Inc. (NYC, USA) has announced to become the first investigative treatment of both neurodegenerative and ocular disease manifestations of Batten Disease.

Phase 2/3 anti-sense treatment (”QR-421a”) of retinitis pigmentosa (RP) aims to use exon skipping within the USH2A gene to repair the shortened usherin protein.

Dutch researchers at the Radboud University Medical Centre, Nijmegen, and ProQR Therapeutics, a company, based in Leiden, the Netherlands, are enrolling up to 200 patients… Read More »Phase 2/3 anti-sense treatment (”QR-421a”) of retinitis pigmentosa (RP) aims to use exon skipping within the USH2A gene to repair the shortened usherin protein.

Evidence shows smoking cessation provides a significant reduction on the risk of progressing to age-related macular (AMD) and alcohol consumption having a causal association with geographic atrophy (GA) risk. 

Researchers at the Institute of Health Informatics, University College London (UCL), and the International AMD Genomics Consortium (IAMDGC), have reported a significant study on an… Read More »Evidence shows smoking cessation provides a significant reduction on the risk of progressing to age-related macular (AMD) and alcohol consumption having a causal association with geographic atrophy (GA) risk. 

A 50-year longitudinal study of diabetes on ocular complications in youth-onset type-2 diabetes (T2D) and type 1 diabetes (T1D) suggest different risks on retinopathy

New longitudinal research in diabetes over a 50-year period in a US study reported that children with type-2 diabetes (T2D) had almost twice the risk… Read More »A 50-year longitudinal study of diabetes on ocular complications in youth-onset type-2 diabetes (T2D) and type 1 diabetes (T1D) suggest different risks on retinopathy

Mutational and phenotypic spectrum in RPE65 patients including seven novel variants among inherited retinal dystrophies (IRD).

Researchers at the Department of Genetics & Genomics, Instituto de Investigacíon Sanitaria-Fundacíon Jiménez Díaz Madrid, have reported a recent study characterizing a mutational and phenotypic… Read More »Mutational and phenotypic spectrum in RPE65 patients including seven novel variants among inherited retinal dystrophies (IRD).